IL327411A - תכשירים רוקחיים הכוללים מרליקסיבט ושימושים שלהם - Google Patents
תכשירים רוקחיים הכוללים מרליקסיבט ושימושים שלהםInfo
- Publication number
- IL327411A IL327411A IL327411A IL32741126A IL327411A IL 327411 A IL327411 A IL 327411A IL 327411 A IL327411 A IL 327411A IL 32741126 A IL32741126 A IL 32741126A IL 327411 A IL327411 A IL 327411A
- Authority
- IL
- Israel
- Prior art keywords
- maralixibat
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2023/034580 WO2025075624A1 (en) | 2023-10-05 | 2023-10-05 | Pharmaceutical compositions comprising maralixibat and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL327411A true IL327411A (he) | 2026-05-01 |
Family
ID=95283600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL327411A IL327411A (he) | 2023-10-05 | 2023-10-05 | תכשירים רוקחיים הכוללים מרליקסיבט ושימושים שלהם |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2023468766A1 (he) |
| IL (1) | IL327411A (he) |
| WO (1) | WO2025075624A1 (he) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2577852A1 (en) * | 2004-08-31 | 2006-03-09 | Pfizer Products Inc. | Pharmaceutical dosage forms comprising a low-solubility drug and a polymer |
| NZ600123A (en) * | 2009-11-30 | 2015-04-24 | Aptalis Pharmatech Inc | Compressible-coated pharmaceutical compositions and tablets and methods of manufacture |
| PL2665471T3 (pl) * | 2011-01-19 | 2018-06-29 | Pathologica, Llc. | Doustne farmaceutyczne postacie dawkowane o kontrolowanym uwalnianiu zawierające mgbg |
| EP2968230A2 (en) * | 2013-03-15 | 2016-01-20 | Lumena Pharmaceuticals, Inc. | Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory bowel disease |
| PT3435996T (pt) * | 2016-03-31 | 2025-05-13 | Genfit | Elafibranor para utilização no tratamento de colangite biliar primária |
| TW202333724A (zh) * | 2021-11-05 | 2023-09-01 | 美商米魯姆製藥公司 | 以迴腸膽酸轉運蛋白(ibat)抑制劑治療以增加無事件存活期(efs) |
-
2023
- 2023-10-05 IL IL327411A patent/IL327411A/he unknown
- 2023-10-05 WO PCT/US2023/034580 patent/WO2025075624A1/en active Pending
- 2023-10-05 AU AU2023468766A patent/AU2023468766A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023468766A1 (en) | 2026-03-26 |
| WO2025075624A1 (en) | 2025-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2611642B (en) | Pharmaceutical and cosmetic compositions comprising secretomes | |
| IL320856A (he) | שילובים פרמצבטיים ושימושים בהם | |
| PT4153133T (pt) | Composições farmacêuticas injetáveis e utilizações das mesmas | |
| ZA202105586B (en) | Pharmaceutical delivery compositions and uses thereof | |
| IL300090A (he) | תכשירי רוקחות המכילים venglustat | |
| IL326970A (he) | תכשירי רוקחות המכילים ניפוקלימאב | |
| IL319382A (he) | תכשיר רוקחות ושימוש בו | |
| GB202215065D0 (en) | Compositions and uses thereof | |
| GB202209335D0 (en) | Compositions and uses thereof | |
| EP4364735A4 (en) | PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| GB202002926D0 (en) | Compositions and uses thereof | |
| CA3304568A1 (en) | Pharmaceutical compositions comprising maralixibat and uses thereof | |
| EP4125873A4 (en) | PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | |
| CA3307498A1 (en) | Pharmaceutical compositions and uses thereof | |
| HK40076361A (en) | Aspacytarabine pharmaceutical compositions and uses thereof | |
| EP4100020A4 (en) | PHARMACEUTICAL ASPACYTARABINE COMPOSITIONS AND USES THEREOF | |
| HK40077387A (en) | Pharmaceutical compositions and their uses | |
| GB202507879D0 (en) | Pharmaceutical composition and uses | |
| NL2027551A (en) | 1immunogenic polypeptides and pharmaceutical compositions | |
| GB202215064D0 (en) | Compositions and uses thereof | |
| GB202213726D0 (en) | Compositions and uses thereof | |
| GB202003316D0 (en) | Pharmaceutical compositions comprising dasatinib anhydrous and uses thereof | |
| GB202210105D0 (en) | Compositions and uses thereof | |
| GB202210107D0 (en) | Compositions and uses thereof | |
| GB202210106D0 (en) | Compositions and uses thereof |